Date: 2025-11-05

In the laboratory of Luobang Shangpin R&D Center, the prototype of the new generation hydrogen oxygen hybrid micro hyperbaric oxygen chamber is undergoing stability testing. We have perfectly integrated the selective antioxidant properties of hydrogen with the physiological regulatory functions of oxygen, solving the oxidative stress problem of traditional oxygen therapy. "The R&D director presented the latest achievements. This hydrogen oxygen synergistic technology, which has obtained three invention patents, can increase the safety of oxygen therapy by three times and expand its applicability to chronic disease patients and health management populations. In the next three years, the brand plans to invest 20 million yuan in research and development funds, focusing on breakthroughs in core technologies such as nanoscale gas mixing and intelligent pressure curve adjustment, to achieve a precise oxygen therapy solution of "one person, one policy", allowing the equipment to automatically adjust treatment parameters based on real-time physiological data of users.
The next generation of products will no longer be isolated devices, but the core nodes of the intelligent and healthy ecosystem, "revealed the product strategy manager of Luobang Shangpin. The portable home oxygen chamber being developed by the brand is 40% smaller in size compared to the first generation product, with a weight controlled within 150 kilograms, and can be easily placed in ordinary households. More noteworthy is the "hardware and software service" ecosystem it has built - connecting health monitoring devices such as blood pressure monitors and oximeters through IoT technology, AI algorithms automatically generate personalized health management plans, and medical expert teams provide 24/7 online consultation. This "prevention intervention rehabilitation" full cycle management model has been piloted in high-end communities in Guangzhou and Shenzhen. Data shows that the incidence rate of respiratory diseases among participants has decreased by 42%, and medical expenditure has decreased by 35%.
At the recent International Medical Device Standardization Conference, the proposal of "Safety Requirements for Household Micro Hyperbaric Oxygen Chambers" led by Lobon Shangpin was approved. When we participate in the development of industry standards, we truly have the power to define the future, "said the brand standardization engineer proudly. Based on 12 patented technologies and over 30000 clinical data, Lobang Shangpin has led or participated in the development of 3 group standards, among which the "staged pressure regulation technical specifications" have been included in the national medical device industry standard revision plan. The brand has also established cooperation with top international institutions such as the Berlin Scherret Medical School and the Mayo Clinic in the United States to promote the global standard construction of micro hyperbaric oxygen therapy technology. Currently, its products have passed the EU CE certification and plan to enter the mainstream markets in Europe and America before 2026.
Our ultimate goal is to provide professional respiratory health services to every family, "emphasized the founder of Lobang Shangpin at the brand strategy launch event. Develop a simplified one click interface and remote monitoring function for the elderly population; Design a fun treatment guidance system for children; Customize a quick recovery plan for sports enthusiasts. This concept of "universal healthcare" has enabled the service network of Lobang Shangpin to cover 28 provinces across the country, serving over 100000 people. As technological innovation continues to lower the entry threshold for health services, and intelligent systems enable professional medical resources to no longer be limited by geography, what Luobang Shangpin is writing is not only the growth history of a brand, but also the industrial evolution history of China's home respiratory health management.
Guangdong Split Point Medical Technology Co., Ltd., under the brand "Luobang Shangpin", is committed to providing solutions for respiratory health and "prevention of diseases", mainly selling micro hyperbaric oxygen chambers Having a complete system of product and technology, supply chain expansion, supporting and encouraging "old leading new", seeking the future together, and gathering at the peak!
Consultation hotline: 400-807-1628
Headquarters Address: 120 Ronggui Avenue North, Shunde District, Foshan City, Guangdong Province
Luobang Shangpin Micro Hyperbaric Oxygen Chamber Official Website: https://www.luobangsp.cn/
